Literature DB >> 16217533

Treatment of hidradenitis suppurativa with botulinum toxin A.

David J O'Reilly, Jonathon M Pleat, Adrian M Richards.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16217533     DOI： 10.1097/01.prs.0000184354.32111.dc

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN： 0032-1052            Impact factor:   4.730


× No keyword cloud information.
  7 in total

Review 1.  Botulinum Toxin Off-Label Use in Dermatology: A Review.

Authors:  Anna Campanati; Emanuela Martina; Katia Giuliodori; Veronica Consales; Ivan Bobyr; Annamaria Offidani
Journal:  Skin Appendage Disord       Date:  2017-02-01

2.  Successful treatment of stage III hidradenitis suppurativa with botulinum toxin A.

Authors:  Weibin Shi; Shannon Schultz; Amy Strouse; David R Gater
Journal:  BMJ Case Rep       Date:  2019-01-20

Review 3.  Hidradenitis suppurativa in children and adolescents: a review of treatment options.

Authors:  Peter Riis Mikkelsen; Gregor B E Jemec
Journal:  Paediatr Drugs       Date:  2014-12       Impact factor: 3.022

Review 4.  Botulinum toxin type A for the management of hidradenitis suppurativa.

Authors:  Huanhuan Qu; Lin Gao
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

Review 5.  Off-Label Use of Botulinum Toxin in Dermatology-Current State of the Art.

Authors:  Miłosz Lewandowski; Zuzanna Świerczewska; Wioletta Barańska-Rybak
Journal:  Molecules       Date:  2022-05-13       Impact factor: 4.927

Review 6.  Botulinum Toxin in the Field of Dermatology: Novel Indications.

Authors:  Yoon Seob Kim; Eun Sun Hong; Hei Sung Kim
Journal:  Toxins (Basel)       Date:  2017-12-16       Impact factor: 4.546

7.  Therapeutic Use of Botulinum Neurotoxins in Dermatology: Systematic Review.

Authors:  Emanuela Martina; Federico Diotallevi; Giulia Radi; Anna Campanati; Annamaria Offidani
Journal:  Toxins (Basel)       Date:  2021-02-05       Impact factor: 4.546
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.